Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Allografting

Peri-engraftment syndrome in allogeneic hematopoietic SCT

Abstract

Engraftment syndrome (ES) and pre-engraftment syndrome (pre-ES) are both inflammatory conditions that occur after hematopoietic SCT (HSCT) and are characterized by non-infectious fever and skin rash. Although the pathogenesis is not fully understood, both syndromes are similar, and could be defined as a new clinical syndrome, named as peri-engraftment syndrome (peri-ES). We retrospectively analyzed the clinical records in 176 pediatric patients, following allogeneic HSCT. We utilized the definition of ES by Spitzer as the diagnostic criteria, excluding ‘within 96 h of engraftment’ criteria. Thirty cases developed peri-ES with a cumulative incidence of 17.0%. High cumulative incidence (50%) was seen in patients who underwent a double-unit cord blood transplantation (DUCBT; P<0.01). Clinical findings of peri-ES are similar, regardless of the onset day, and encephalopathy was the most severe complication. In the DUCBT cohort, the use of TBI and early complete chimerism (day 21) were identified as risk factors that predispose the development of peri-ES. We determined that both, ES and pre-ES, might have similar causes, which could be included in peri-ES. Particularly, it occurred more in DUCBT patients, which means that not only neutrophil engraftment but also immune reactions within the two units might contribute to peri-ES.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Spitzer TR . Engraftment syndrome following hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 27: 893–898.

    Article  CAS  PubMed  Google Scholar 

  2. Maiolino A, Biasoli I, Lima J, Portugal AC, Pulcheri W, Nucci M . Engraftment syndrome following autologous hematopoietic stem cell transplantation: definition of diagnostic criteria. Bone Marrow Transplant 2003; 31: 393–397.

    Article  CAS  PubMed  Google Scholar 

  3. Nishio N, Yagasaki H, Takahashi Y, Hama A, Muramatsu H, Tanaka M et al. Engraftment syndrome following allogeneic hematopoietic stem cell transplantation in children. Pediatr Transplant 2009; 13: 831–837.

    Article  CAS  PubMed  Google Scholar 

  4. Schmid I, Stachel D, Pagel P, Albert MH . Incidence, predisposing factors, and outcome of engraftment syndrome in pediatric allogeneic stem cell transplant recipients. Biol Blood Marrow Transplant 2008; 14: 438–444.

    Article  PubMed  Google Scholar 

  5. González-Vicent M, Ramírez M, Sevilla J, Pérez A, Fernández S, Madero L et al. Engraftment syndrome after autologous peripheral blood progenitor cell transplantation in pediatric patients: a prospective evaluation of risk factors and outcome. Bone Marrow Transplant 2004; 34: 1051–1055.

    Article  PubMed  Google Scholar 

  6. Foncillas MA, Diaz MA, Sevilla J, Gonzalez Vicent M, Fernandez-Plaza S, Perez A et al. Engraftment syndrome emerges as the main cause of transplant-related mortality in pediatric patients receiving autologous peripheral blood progenitor cell transplantation. J Pediatr Hematol Oncol 2004; 26: 492–496.

    Article  PubMed  Google Scholar 

  7. Carreras E, Fernández-Avilés F, Silva L, Guerrero M, de Larrea CF, Martínez C et al. Engraftment syndrome after auto-SCT: analysis of diagnostic criteria and risk factors in a large series from a single center. Bone Marrow Transplant 2010; 45: 1417–1422.

    Article  CAS  PubMed  Google Scholar 

  8. Patel KJ, Rice RD, Hawke R, Abboud M, Heller G, Scaradavou A et al. Pre-engraftment syndrome after double-unit cord blood transplantation: a distinct syndrome not associated with acute graft-versus-host disease. Biol Blood Marrow Transplant 2010; 16: 435–440.

    Article  PubMed  Google Scholar 

  9. Frangoul H, Wang L, Harrell FE, Ho R, Domm J . Preengraftment syndrome after unrelated cord blood transplant is a strong predictor of acute and chronic graft-versus-host disease. Biol Blood Marrow Transplant 2009; 15: 1485–1488.

    Article  CAS  PubMed  Google Scholar 

  10. Wang X, Liu H, Li L, Geng L, Ding K, Liu X et al. Pre-engraftment syndrome after unrelated donor umbilical cord blood transplantation in patients with hematologic malignancies. Eur J Haematol 2012; 88: 39–45.

    Article  CAS  PubMed  Google Scholar 

  11. Lee YH, Lim YJ, Kim JY, Kim YD, Lee SW . Pre-engraftment Syndrome in Hematopoietic Stem Cell Transplantation. J Korean Med Sci 2008; 23: 98–103.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Kim H, Shin D, Lee JW, Jang MK, Park KD, Shin HY et al. Successful empirical antifungal therapy of intravenous itraconazole with pharmacokinetic evidence in pediatric cancer patients undergoing hematopoietic stem cell transplantation. Blood (ASH Annual Meeting Abstracts) 2011; 118: 3019.

    Google Scholar 

  13. Kang HJ, Shin HY, Choi HS, Ahn HS . Fludarabine cyclophosphamide plus thymoglobulin conditioning regimen for unrelated bone marrow transplantation in severe aplastic anemia. Bone Marrow Transplant 2004; 34: 939–943.

    Article  CAS  PubMed  Google Scholar 

  14. Kang HJ, Kho SH, Jang MK, Lee SH, Shin HY, Ahn HS . Early engraftment kinetics of two units cord blood transplantation. Bone Marrow Transplant 2006; 38: 197–201.

    Article  CAS  PubMed  Google Scholar 

  15. Park M, Koh KN, Kim BE, Im HJ, Park KD, Kang HJ et al. The impact of HLA matching on unrelated donor hematopoietic stem cell transplantation in Korean children. Korean J Hematol 2011; 46: 11–17.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15: 825–828.

    CAS  PubMed  Google Scholar 

  17. Sullivan KM, Agura E, Anasetti C, Appelbaum F, Badger C, Bearman S et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol 1991; 28: 250–259.

    CAS  PubMed  Google Scholar 

  18. Kang HJ, Yoo KH, Lee JW, Kim H, Lee SH, Sung KW et al. Double umbilical cord blood transplantation for children and adolescents. Ann Hematol 2010; 89: 1035–1044.

    Article  PubMed  PubMed Central  Google Scholar 

  19. de Pagter PJ, Schuurman R, Meijer E, van Baarle D, Sanders EAM, Boelens JJ . Human herpesvirus type 6 reactivation after haematopoietic stem cell transplantation. J Clin Virol 2008; 43: 361–366.

    Article  CAS  PubMed  Google Scholar 

  20. Sideri A, Neokleous N, De La Grange PB, Guerton B, Le Bousse Kerdilles MC, Uzan G et al. An overview of the progress on double umbilical cord blood transplantation. Haematologica 2011; 96: 1213–1220.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Barker JN . Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 2004; 105: 1343–1347.

    Article  PubMed  Google Scholar 

  22. Gutman JA, Turtle CJ, Manley TJ, Heimfeld S, Bernstein ID, Riddell SR et al. Single-unit dominance after double-unit umbilical cord blood transplantation coincides with a specific CD8+ T-cell response against the nonengrafted unit. Blood 2009; 115: 757–765.

    Article  PubMed  Google Scholar 

  23. Majhail NS, Brunstein CG, Wagner JE . Double umbilical cord blood transplantation. Curr Opin Immunol 2006; 18: 571–575.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This study was supported by a grant of the Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A102065) and by a grant (11172KFDA288) from Korea Food & Drug Administration in 2011.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H J Kang.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hong, K., Kang, H., Kim, N. et al. Peri-engraftment syndrome in allogeneic hematopoietic SCT. Bone Marrow Transplant 48, 523–528 (2013). https://doi.org/10.1038/bmt.2012.171

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2012.171

Keywords

This article is cited by

Search

Quick links